— Know what they know.
Not Investment Advice

TAUG OTC

Tauriga Sciences, Inc.
1W: -90.0% 1M: -90.0% 3M: -90.0% 1Y: -100.0% 3Y: -100.0% 5Y: -100.0%
$0.00
Last traded 2023-08-11 — delisted
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · $2999 mcap · 293M float · 0.0005% daily turnover

Income Trends

Revenue
$285K +21.7% ▲
Gross Profit
$123K +229.7% ▲
Operating Income
-$3M -66.2% ▼
Net Income
-$4M -19.6% ▼
EPS (Diluted)
$-0.02 +49.8% ▲
EBITDA
-$3M -66.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$0$1K$57K$234K$285K
YoY Growth+0.0%+0.0%+4709.3%+310.2%+21.7%
Cost of Revenue$7K$715$37K$197K$163K
Gross Profit-$7K$473$20K$37K$123K
Gross Margin—39.8%35.0%15.9%43.0%
R&D Expenses$109K$10K$14K$7K$273K
SG&A Expenses$1M$2M$1M$2M$3M
Operating Expenses$2M$2M$1M$2M$4M
Operating Income-$2M-$2M-$1M-$2M-$3M
Operating Margin—-159542.1%-1895.7%-869.9%-1188.0%
Interest Expense$721K$292K$281K$902K$1M
Income Before Tax-$2M$3K-$1M-$3M-$4M
Tax Expense$0$39K$2K$902K$1M
Net Income-$2M-$36K-$1M-$3M-$4M
Net Margin—-3041.0%-1920.8%-1294.1%-1271.0%
EPS (Diluted)$-0.11$-0.00$-0.02$-0.05$-0.02
EBITDA-$1M-$2M-$816K-$2M-$3M
Shares Outstanding19M56M56M81M194M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms